James is an Investment Principal at Oxford Sciences Innovation (OSI) and joined the SpyBiotech board in November 2020, bringing venture capital, corporate and board experience focused on healthcare in the UK and internationally.
In addition to SpyBiotech, James also represents OSI on the board of Oxford Nanoimaging. Prior to OSI, James was Head of Corporate Advisory at Mercia Asset Management. Before this, he was Investment Director at Fosun Pharma in China, responsible for venture capital investments, including university IP commercialisation funds and spin-out companies. This built on his experience as Investment Manager at NBGI Ventures, where he focused on medical technology and served on the board of several portfolio companies in the UK, Europe and the US. He entered venture capital after starting his career at Cambridge Consultants in 2006.
James holds an EPSRC-funded MPhil in Computational Biology from the University of Cambridge. He is a Mentor on the MedTech SuperConnector led by Imperial College London and a Fellow of the Royal Society of Arts.